# A Study of LY2484595 in Healthy Subjects

> **NCT01450098** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY2484595 Reference Formulation (RF)
- **DRUG:** LY2484595 spray-dried solid dispersion-propyl gallate (SDSD-PG)

## Key facts

- **NCT ID:** NCT01450098
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01450098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01450098, "A Study of LY2484595 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01450098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*